Cohort Studies

Ozaltin, B., Chapman, R., Arfeen, M. Q. U., Fitzpatick, N., Hemingway, H., Direk, K., & Jacob, J. (2024). Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study. Respir Res, 25, 249. http://doi.org/10.1186/s12931-024-02875-2
Matias, M. A., Jacobs, R., Aragón, M. J., Fernandes, L., Gutacker, N., Siddiqi, N., & Kasteridis, P. (2024). Assessing the uptake of incentivised physical health checks for people with serious mental illness: a cohort study in primary care. Br J Gen Pract, 74, e449-e455. http://doi.org/10.3399/bjgp.2023.0532
Gupta, R., Morgan, A. D., George, P. M., & Quint, J. K. (2024). Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study. Thorax, 79, 624-631. http://doi.org/10.1136/thorax-2023-220887
Jayasooriya, N., Saxena, S., Blackwell, J., Bottle, A., Creese, H., Petersen, I., & Pollok, R. C. G. (2024). Associations between prior healthcare use, time to diagnosis, and clinical outcomes in inflammatory bowel disease: a nationally representative population-based cohort study. Bmj Open Gastroenterol, 11. http://doi.org/10.1136/bmjgast-2024-001371
Ahmed, H., Reeve, N., Farewell, D., Hamilton, F., Ponsford, M., Hippisley-Cox, J., & Noble, S. (2024). Risk of bleeding amongst warfarin and direct oral anticoagulant users prescribed immediate antibiotics for respiratory tract infection: Cohort study. Pharmacoepidemiol Drug Saf, 33, e5794. http://doi.org/10.1002/pds.5794
Reyes, C., Newby, D., Raventós, B., Verhamme, K., Mosseveld, M., Prieto-Alhambra, D., et al. (2024). Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study. Age Ageing, 53. http://doi.org/10.1093/ageing/afae106
Simms-Williams, N., Nagakumar, P., Thayakaran, R., Adderley, N. J., Hotham, R., Mansur, A. H., et al. (2024). Risk factors for asthma-related hospital and intensive care admissions in children, adolescents and adults: a cohort study using primary and secondary care data. Bmj Open Respir Res, 11. http://doi.org/10.1136/bmjresp-2023-001746
Mok, P. L. H., Carr, M. J., Guthrie, B., Morales, D. R., Sheikh, A., Elliott, R. A., et al. (2024). Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study. Bmj, 385, e076268. http://doi.org/10.1136/bmj-2023-076268
Simms-Williams, N., Treves, N., Yin, H., Lu, S., Yu, O., Pradhan, R., et al. (2024). Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. Bmj, 385, e078242. http://doi.org/10.1136/bmj-2023-078242
Català, M., Mercadé-Besora, N., Kolde, R., Trinh, N. T. H., Roel, E., Burn, E., et al. (2024). The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med, 12, 225-236. http://doi.org/10.1016/s2213-2600(23)00414-9